Passage Bio Inc. Common Stock (PASG)
Stock · NASDAQ · Health Care
$3.5as of 10/16/2026
Price chart
Active signals
PASG Signal Track Record
How signals performed across all stocks →What PASG's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 31 | -6.5% | 45% | September 14, 2026 |
| Bollinger Band Breakdown | 20 | -3.3% | 45% | September 30, 2026 |
| Bollinger Band Breakout | 18 | +0.7% | 50% | August 25, 2026 |
| 200-Day Moving Average TouchActive now | 4 | -13.6% | 25% | November 21, 2025 |
| Any 20-session window (baseline) | -5.7% | 35% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About PASG
Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases. It develops PBFT02, a functional granulin (GRN) and gene encoding progranulin (PGRN) for the treatment of FTD caused by progranulin deficiency; PBGM01, a functional GLB1 gene encoding ß-galactosidase for infantile GM1; and PBKR03, for the treatment of Krabbe disease. The company develops PBML04 for the treatme…
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Employees
- 24
- Website
- www.passagebio.com/
Fundamentals
- 1-day range
- $3.37$3.76
- Market cap
- $14.11M
- P/E (trailing)
- —
- P/E (forward)
- -0.33
- EPS (trailing)
- $-11.32
- Dividend yield
- —
- Beta
- 1.48
- Avg. volume
- 22.9K
Forecasts
2 analyst ratings
Passage Bio Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- PASGPassage Bio Inc. Common Stock$3.5▼ 2.78%Market cap $14.11MP/E —$3.29$20
- INTSIntensity Therapeutics Inc. Common stock$3.35▼ 0.89%Market cap $11.49MP/E —$3.1$43.5
- SNTISenti Biosciences Holdings Inc. Common Stock$0.225▼ 14.12%Market cap $11.18MP/E —$0.2399$2.88
- BCDABioCardia Inc. Common Stock$0.92▼ 2.13%Market cap $10.80MP/E —$0.75$1.8
- JSPRJasper Therapeutics Inc. Common Stock$0.48▼ 9.77%Market cap $18.10MP/E —$0.3151$2.69
- INABIN8bio Inc. Common Stock$1.11▼ 6.33%Market cap $9.55MP/E —$0.88$2.73
- PLURPluri Inc. Common Stock$0.93▼ 1.06%Market cap $19.53MP/E —$0.9$4.87
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| PASG Passage Bio Inc. Common Stock | $14.11M | — | $3.5 | ▼ 2.78% | $3.29$20 |
| INTS Intensity Therapeutics Inc. Common stock | $11.49M | — | $3.35 | ▼ 0.89% | $3.1$43.5 |
| SNTI Senti Biosciences Holdings Inc. Common Stock | $11.18M | — | $0.225 | ▼ 14.12% | $0.2399$2.88 |
| BCDA BioCardia Inc. Common Stock | $10.80M | — | $0.92 | ▼ 2.13% | $0.75$1.8 |
| JSPR Jasper Therapeutics Inc. Common Stock | $18.10M | — | $0.48 | ▼ 9.77% | $0.3151$2.69 |
| INAB IN8bio Inc. Common Stock | $9.55M | — | $1.11 | ▼ 6.33% | $0.88$2.73 |
| PLUR Pluri Inc. Common Stock | $19.53M | — | $0.93 | ▼ 1.06% | $0.9$4.87 |
P/E shows — for peers not currently carrying a live signal of their own.
Insider Activity
Insider Actions →- Sondhi Dolan · May 19, 2026 · Grant10.5K
- Derrell Porter · May 19, 2026 · Grant10.5K
- Kapadia Sandip · May 19, 2026 · Grant10.5K
- Athena Countouriotis · May 19, 2026 · Grant10.5K
- Kassberg Thomas Richard · May 19, 2026 · Grant10.5K
- GOWEN MAXINE · May 19, 2026 · Grant10.5K
Institutional Ownership
March 31, 2026
- Total shares held
- 1.76M
- Total value held
- $13.50M
- Institutional holders
- 32
- Unknown623.7K
- Unknown305.0K
- Unknown133.6K
- Unknown131.6K
- Unknown114.0K
- Unknown86.1K
- Unknown85.3K
- Unknown68.1K
- Unknown41.4K
- Unknown28.6K
See the full, filterable feed with live charts on the MarketWall dashboard.